Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-20

Clinical Trial Update: Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients [NA]

View source ↗

Summary

A clinical trial update reports that thalidomide exposure in reproductive-age females with Crohn's disease may be associated with diminished ovarian reserve.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn Disease | NA | Status: UNKNOWN